Plasma Resuscitation Without Lung Injury (PROPOLIS)
Plasma Resuscitation withOut Lung Injury
Sponsor: Cerus Corporation
Terminated
Enrollment targets were unable to be reached due to difficulty in locating and contacting the Legally Authorized Representative (LAR). Even with prolonged enrollment timeframe, the study was unable to obtain consent from the LAR.
Other terminated trials from Cerus Corporation
More terminations from Cerus Corporation
This PHASE4 trial investigates Burns and is currently terminated or withdrawn. Cerus Corporation leads this study, which shows 10 recorded versions since 2022 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Jun 2025 — Present [monthly]
Terminated PHASE4
-
Feb 2025 — Jun 2025 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Sep 2024 — Feb 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Oct 2023 — Jul 2024 [monthly]
Recruiting PHASE4
▶ Show 5 earlier versions
-
Jun 2023 — Oct 2023 [monthly]
Recruiting PHASE4
-
Mar 2023 — Jun 2023 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Sep 2022 — Mar 2023 [monthly]
Not Yet Recruiting PHASE4
-
Sep 2021 — Sep 2022 [monthly]
Not Yet Recruiting PHASE4
-
Jan 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Cerus Corporation
- Coalition for National Trauma Research
For direct contact, visit the study record on ClinicalTrials.gov .